Dr. Matt Wheeler is an associate in the patents and innovations practice group in Wilson Sonsini Goodrich & Rosati’s San Diego office, where he provides strategic patent counseling to clients on a wide variety of technologies. Matt’s scientific expertise includes antibodies, biologics, diagnostics, and medical devices.
Matt works with clients at all stages, from start-ups to public companies, to develop and implement global patent strategies. His counseling experience includes freedom to operate analysis; due diligence for mergers and acquisitions, private financings, and public markets; and all stages of preparation and prosecution of patent filings in the U.S. and around the world, including post-grant procedures.
Matt first joined Wilson Sonsini as a patent agent in 2014 and transitioned to an associate role after attending law school at the University of San Diego.
Prior to joining the firm, Matt obtained his Ph.D. in biomedical sciences from UC San Diego, where he studied immunology and antibody engineering. After receiving his Ph.D., Matt conducted postdoctoral studies at The Scripps Research Institute where he studied the role ER stress plays in inflammation and metabolic diseases.
Dr. Matt Wheeler is an associate in the patents and innovations practice group in Wilson Sonsini Goodrich & Rosati’s San Diego office, where he provides strategic patent counseling to clients on a wide variety of technologies. Matt’s scientific expertise includes antibodies, biologics, diagnostics, and medical devices.
Matt works with clients at all stages, from start-ups to public companies, to develop and implement global patent strategies. His counseling experience includes freedom to operate analysis; due diligence for mergers and acquisitions, private financings, and public markets; and all stages of preparation and prosecution of patent filings in the U.S. and around the world, including post-grant procedures.
Matt first joined Wilson Sonsini as a patent agent in 2014 and transitioned to an associate role after attending law school at the University of San Diego.
Prior to joining the firm, Matt obtained his Ph.D. in biomedical sciences from UC San Diego, where he studied immunology and antibody engineering. After receiving his Ph.D., Matt conducted postdoctoral studies at The Scripps Research Institute where he studied the role ER stress plays in inflammation and metabolic diseases.